LCTX - Lineage Cell Therapeutics GAAP EPS of -$0.03 beats by $0.01 revenue of $2.39M beats by $0.38M
2023-05-11 16:51:39 ET
- Lineage Cell Therapeutics press release ( NYSE: LCTX ): Q1 GAAP EPS of -$0.03 beats by $0.01 .
- Revenue of $2.39M (-54.4% Y/Y) beats by $0.38M .
For further details see:
Lineage Cell Therapeutics GAAP EPS of -$0.03 beats by $0.01, revenue of $2.39M beats by $0.38M